EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Advances in drug prevention and treatment of radiation‑induced lung injury (Review)

Shuo Liu, Minting Ma, Chanjun Zhen, Yang Zhao, Yuzhi Song, Qiuying An, Zhiguo Zhou, Wenwen Bai

Experimental and Therapeutic Medicine · 29.09.2026 · 32 (5) · 1-12

DOI: 10.3892/etm.2026.13318 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Experimental and Therapeutic Medicine, online erschienen am 29.09.2026. Verfasst von Shuo Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiation-induced lung injury (RILI), including radiation pneumonitis and radiation-induced pulmonary fibrosis, is a common complication during or after radiotherapy for thoracic tumors. This complication severely restricts dose escalation in radiotherapy and delays subsequent antitumor treatment, thereby compromising patient prognosis. Therefore, it is crucial to develop safe and effective drug prevention and treatment strategies to ensure successful implementation of radiotherapy and improve patient prognosis. The present review systematically assesses recent advances in drug prevention and treatment-based approaches for RILI, focusing on the underlying molecular mechanisms and key therapeutic targets at different developmental phases of RILI (oxidative stress, inflammatory response and fibrosis formation). Progress from classical radioprotective agents and anti-inflammatory drugs to novel antifibrotic drugs and cutting-edge exploratory therapies are also comprehensively summarized, with an aim to inform clinical practice and guide future research directions.

Schlagwörter

Stichwörter der Autor:innen

drug preventionradiation pneumonitisradiation-induced lung injuryradiation-induced pulmonary fibrosistreatment

Autor:innen und Institutionen

  • Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China.
  • Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China.
  • Office of Scientific Research, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China.

Zitieren

APA

Liu, S., Ma, M., Zhen, C., Zhao, Y., Song, Y., An, Q., Zhou, Z., & Bai, W. (2026). Advances in drug prevention and treatment of radiation‑induced lung injury (Review). Experimental and Therapeutic Medicine, 32(5), 1-12. https://doi.org/10.3892/etm.2026.13318

Vancouver

Liu S, Ma M, Zhen C, Zhao Y, Song Y, An Q, et al. Advances in drug prevention and treatment of radiation‑induced lung injury (Review). Experimental and Therapeutic Medicine. 2026;32(5):1-12. doi:10.3892/etm.2026.13318

BibTeX
@article{Liu2026,
  author = {Liu, Shuo and Ma, Minting and Zhen, Chanjun and Zhao, Yang and Song, Yuzhi and An, Qiuying and Zhou, Zhiguo and Bai, Wenwen},
  title = {Advances in drug prevention and treatment of radiation‑induced lung injury (Review)},
  journal = {Experimental and Therapeutic Medicine},
  year = {2026},
  volume = {32},
  number = {5},
  pages = {1--12},
  doi = {10.3892/etm.2026.13318}
}
Kostenlos starten →